Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.

Biotechnology

Denali Therapeutics

Denali Therapeutics' headquarters in South San Francisco, CA, United States

Ryan Watts

Alex Schuth

Dana Andersen

Erica Kratz

Joe Lewcock

Katie Peng

Terry Hudson

Scott Moore

Vikram S.

Chris Walsh

Cindy Dunkle

Steve Krognes

Jay Flatley

Peter Klein

David Schenkein

Marc Tessier-Lavigne

Nancy A. Thornberry

Jennifer Cook

Vicki L. Sato

Erik Harris

The Clinical and Development team at Denali Therapeutics is responsible for spearheading the design, execution, and oversight of both early and late-stage clinical trials, along with regulatory compliance and safety monitoring. This team collaborates across scientific discovery, clinical manufacturing, translational medicine, and drug safety to advance potential treatments from the laboratory through to approval, ensuring the delivery of safe and effective therapies for neurodegenerative diseases.

Clinical and Development

The Leadership Team at Denali Therapeutics is responsible for setting the strategic direction and overseeing the execution of the company's mission to combat neurodegenerative diseases. Comprising key executives from various functions, the team collaborates on scientific research, clinical development, and operational efficiencies to ensure the delivery of innovative and effective therapies to patients. They drive cross-functional initiatives, foster a culture of excellence, and engage stakeholders to advance Denali's goals in the biotech landscape.

Leadership Team

The Board Members at Denali Therapeutics provide strategic oversight and governance, ensuring the company stays true to its mission of defeating neurodegenerative diseases. They guide executive decisions, oversee financial health, and uphold the highest ethical standards in scientific research and clinical development.

Board Members

The Executive Management Team at Denali Therapeutics oversees the strategic direction and daily operations of the company. Comprised of top executives including the CEO, Chief People Officer, Chief Medical Officer, and other key leaders, this team is responsible for driving innovation, ensuring corporate governance, managing financial health, and spearheading efforts to develop and deliver effective treatments for neurodegenerative diseases.

Executive Management Team

The Vice Presidents at Denali Therapeutics are senior leaders responsible for guiding strategic initiatives across various functions, including investor relations, biometrics, European development, intellectual property and transactions, chemistry, manufacturing, and controls (CMC), and global product strategy and U.S. market access. They play a crucial role in advancing the company's mission to develop effective treatments for neurodegenerative diseases by leveraging their expertise and ensuring cross-functional alignment.

Vice Presidents

The Corporate Finance and Development team at Denali Therapeutics manages the company's financial strategy, oversees mergers and acquisitions, ensures accurate financial reporting, and drives long-term growth initiatives to support the mission of delivering breakthroughs in neurodegenerative disease treatments.

��

Denali Therapeutics

Org chart

Board & advisors

Teams

Clinical and Development

Leadership Team

Board Members

Executive Management Team

Vice Presidents

Corporate Finance and Development

Offices

��������

Denali Therapeutics

Org chart

Board & advisors

Teams

Clinical and Development

Leadership Team

Board Members

Executive Management Team

Vice Presidents

Corporate Finance and Development

Offices

Related companies

��